nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—Pigmentation disorder—Methimazole—Graves' disease	0.0559	0.0921	CcSEcCtD
Ribavirin—Pigmentation disorder—Propylthiouracil—Graves' disease	0.0475	0.0783	CcSEcCtD
Ribavirin—ENPP1—connective tissue—Graves' disease	0.0404	0.112	CbGeAlD
Ribavirin—Lung infiltration—Propylthiouracil—Graves' disease	0.0338	0.0557	CcSEcCtD
Ribavirin—Interstitial pneumonia—Propylthiouracil—Graves' disease	0.0328	0.0541	CcSEcCtD
Ribavirin—ENPP1—adipose tissue—Graves' disease	0.031	0.0858	CbGeAlD
Ribavirin—SLC28A3—adipose tissue—Graves' disease	0.0272	0.0754	CbGeAlD
Ribavirin—ENPP1—thyroid gland—Graves' disease	0.0269	0.0743	CbGeAlD
Ribavirin—IMPDH1—eye—Graves' disease	0.0249	0.0689	CbGeAlD
Ribavirin—Ageusia—Methimazole—Graves' disease	0.023	0.0379	CcSEcCtD
Ribavirin—NT5C2—pituitary gland—Graves' disease	0.0228	0.063	CbGeAlD
Ribavirin—NT5C2—adipose tissue—Graves' disease	0.0227	0.0627	CbGeAlD
Ribavirin—Glucosamine—IFNG—Graves' disease	0.0224	0.705	CrCbGaD
Ribavirin—Interstitial lung disease—Propylthiouracil—Graves' disease	0.0224	0.0369	CcSEcCtD
Ribavirin—NT5C2—thyroid gland—Graves' disease	0.0196	0.0543	CbGeAlD
Ribavirin—Ageusia—Propylthiouracil—Graves' disease	0.0196	0.0323	CcSEcCtD
Ribavirin—IMPDH1—pituitary gland—Graves' disease	0.0185	0.0511	CbGeAlD
Ribavirin—IMPDH1—adipose tissue—Graves' disease	0.0184	0.0509	CbGeAlD
Ribavirin—Aplastic anaemia—Methimazole—Graves' disease	0.0175	0.0289	CcSEcCtD
Ribavirin—Vasculitis—Propylthiouracil—Graves' disease	0.0162	0.0268	CcSEcCtD
Ribavirin—SLC29A1—connective tissue—Graves' disease	0.0161	0.0445	CbGeAlD
Ribavirin—IMPDH1—thyroid gland—Graves' disease	0.0159	0.0441	CbGeAlD
Ribavirin—Lymphadenopathy—Methimazole—Graves' disease	0.0159	0.0261	CcSEcCtD
Ribavirin—Aplastic anaemia—Propylthiouracil—Graves' disease	0.0149	0.0245	CcSEcCtD
Ribavirin—ADK—pituitary gland—Graves' disease	0.0146	0.0403	CbGeAlD
Ribavirin—ADK—adipose tissue—Graves' disease	0.0145	0.0401	CbGeAlD
Ribavirin—Lymphadenopathy—Propylthiouracil—Graves' disease	0.0135	0.0222	CcSEcCtD
Ribavirin—Hepatic failure—Propylthiouracil—Graves' disease	0.0128	0.0211	CcSEcCtD
Ribavirin—ADK—thyroid gland—Graves' disease	0.0126	0.0347	CbGeAlD
Ribavirin—SLC29A1—pituitary gland—Graves' disease	0.0124	0.0343	CbGeAlD
Ribavirin—SLC29A1—adipose tissue—Graves' disease	0.0123	0.0342	CbGeAlD
Ribavirin—SLC29A1—thyroid gland—Graves' disease	0.0107	0.0296	CbGeAlD
Ribavirin—Neuropathy peripheral—Methimazole—Graves' disease	0.0102	0.0169	CcSEcCtD
Ribavirin—Jaundice—Methimazole—Graves' disease	0.0102	0.0168	CcSEcCtD
Ribavirin—Glucosamine—TNF—Graves' disease	0.00939	0.295	CrCbGaD
Ribavirin—Hepatitis—Methimazole—Graves' disease	0.00936	0.0154	CcSEcCtD
Ribavirin—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00869	0.0143	CcSEcCtD
Ribavirin—Jaundice—Propylthiouracil—Graves' disease	0.00865	0.0142	CcSEcCtD
Ribavirin—Alopecia—Methimazole—Graves' disease	0.00828	0.0136	CcSEcCtD
Ribavirin—Haemoglobin—Propylthiouracil—Graves' disease	0.008	0.0132	CcSEcCtD
Ribavirin—Hepatitis—Propylthiouracil—Graves' disease	0.00796	0.0131	CcSEcCtD
Ribavirin—Haemorrhage—Propylthiouracil—Graves' disease	0.00796	0.0131	CcSEcCtD
Ribavirin—Vertigo—Methimazole—Graves' disease	0.00732	0.0121	CcSEcCtD
Ribavirin—Leukopenia—Methimazole—Graves' disease	0.0073	0.012	CcSEcCtD
Ribavirin—Alopecia—Propylthiouracil—Graves' disease	0.00704	0.0116	CcSEcCtD
Ribavirin—Myalgia—Methimazole—Graves' disease	0.00694	0.0114	CcSEcCtD
Ribavirin—Arthralgia—Methimazole—Graves' disease	0.00694	0.0114	CcSEcCtD
Ribavirin—Dysgeusia—Propylthiouracil—Graves' disease	0.00679	0.0112	CcSEcCtD
Ribavirin—Oedema—Methimazole—Graves' disease	0.00665	0.011	CcSEcCtD
Ribavirin—Thrombocytopenia—Methimazole—Graves' disease	0.00651	0.0107	CcSEcCtD
Ribavirin—Vertigo—Propylthiouracil—Graves' disease	0.00623	0.0103	CcSEcCtD
Ribavirin—Leukopenia—Propylthiouracil—Graves' disease	0.0062	0.0102	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Methimazole—Graves' disease	0.00606	0.00999	CcSEcCtD
Ribavirin—Paraesthesia—Methimazole—Graves' disease	0.00597	0.00984	CcSEcCtD
Ribavirin—Somnolence—Methimazole—Graves' disease	0.00591	0.00975	CcSEcCtD
Ribavirin—Arthralgia—Propylthiouracil—Graves' disease	0.0059	0.00972	CcSEcCtD
Ribavirin—Myalgia—Propylthiouracil—Graves' disease	0.0059	0.00972	CcSEcCtD
Ribavirin—Dyspepsia—Methimazole—Graves' disease	0.00586	0.00965	CcSEcCtD
Ribavirin—Oedema—Propylthiouracil—Graves' disease	0.00566	0.00932	CcSEcCtD
Ribavirin—Thrombocytopenia—Propylthiouracil—Graves' disease	0.00554	0.00913	CcSEcCtD
Ribavirin—Urticaria—Methimazole—Graves' disease	0.00529	0.00871	CcSEcCtD
Ribavirin—Body temperature increased—Methimazole—Graves' disease	0.00526	0.00867	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.00515	0.00849	CcSEcCtD
Ribavirin—Paraesthesia—Propylthiouracil—Graves' disease	0.00508	0.00837	CcSEcCtD
Ribavirin—Somnolence—Propylthiouracil—Graves' disease	0.00503	0.00829	CcSEcCtD
Ribavirin—Dyspepsia—Propylthiouracil—Graves' disease	0.00498	0.00821	CcSEcCtD
Ribavirin—Pruritus—Methimazole—Graves' disease	0.00471	0.00776	CcSEcCtD
Ribavirin—Urticaria—Propylthiouracil—Graves' disease	0.00449	0.00741	CcSEcCtD
Ribavirin—Body temperature increased—Propylthiouracil—Graves' disease	0.00447	0.00737	CcSEcCtD
Ribavirin—Vomiting—Methimazole—Graves' disease	0.00423	0.00697	CcSEcCtD
Ribavirin—Rash—Methimazole—Graves' disease	0.0042	0.00691	CcSEcCtD
Ribavirin—Dermatitis—Methimazole—Graves' disease	0.00419	0.00691	CcSEcCtD
Ribavirin—Headache—Methimazole—Graves' disease	0.00417	0.00687	CcSEcCtD
Ribavirin—Pruritus—Propylthiouracil—Graves' disease	0.004	0.0066	CcSEcCtD
Ribavirin—Nausea—Methimazole—Graves' disease	0.00395	0.00651	CcSEcCtD
Ribavirin—Vomiting—Propylthiouracil—Graves' disease	0.0036	0.00593	CcSEcCtD
Ribavirin—Rash—Propylthiouracil—Graves' disease	0.00357	0.00588	CcSEcCtD
Ribavirin—Dermatitis—Propylthiouracil—Graves' disease	0.00356	0.00587	CcSEcCtD
Ribavirin—Headache—Propylthiouracil—Graves' disease	0.00354	0.00584	CcSEcCtD
Ribavirin—Nausea—Propylthiouracil—Graves' disease	0.00336	0.00554	CcSEcCtD
